Related Experiment Video
Updated: Feb 27, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation
Alexander Arthur Wurm1, Polina Zjablovskaja2, Miroslava Kardosova2
1Division of Hematology and Oncology, Leipzig University Hospital, Johannisallee 32a, Leipzig, 04103, Germany.
Abstract:
Transcription factor C/EBPα is a master regulator of myelopoiesis and its inactivation is associated with acute myeloid leukemia. Deregulation of C/EBPα by microRNAs during granulopoiesis or acute myeloid leukemia development has not been studied. Here we show that oncogenic miR-182 is a strong regulator of C/EBPα. Moreover, we identify a regulatory loop between C/EBPα and miR-182. While C/EBPα blocks miR-182 expression by direct promoter binding during myeloid differentiation, enforced expression of miR-182 reduces C/EBPα protein level and impairs granulopoiesis in vitro and in vivo. In addition, miR-182 expression is highly elevated particularly in acute myeloid leukemia patients with C-terminal CEBPA mutations, thereby depicting a mechanism by which C/EBPα blocks miR-182 expression. Furthermore, we present miR-182 expression as a prognostic marker in cytogenetically high-risk acute myeloid leukemia patients. Our data demonstrate the importance of a controlled balance between C/EBPα and miR-182 for the maintenance of healthy granulopoiesis.C/EBPα is a critical transcription factor involved in myelopoiesis and its inactivation is associated with acute myeloid leukemia (AML). Here the authors show a negative feedback loop between C/EBPα and miR-182 and identify this miRNA as a marker of high-risk AML.
Insights
Transcription factor CCAAT enhancer-binding protein alpha (C/EBPα) and microRNA-182 (miR-182) form a regulatory loop impacting myeloid differentiation. Dysregulation contributes to acute myeloid leukemia, with miR-182 serving as a high-risk marker.
Area of Science:
- Molecular Biology
- Hematology
- Oncology
Background:
- Transcription factor CCAAT enhancer-binding protein alpha (C/EBPα) is crucial for myelopoiesis.
- Inactivation of C/EBPα is linked to acute myeloid leukemia (AML).
- The role of microRNAs (miRNAs) in C/EBPα deregulation during granulopoiesis and AML remains unclear.
Purpose of the Study:
- Investigate the regulatory relationship between C/EBPα and specific miRNAs during myeloid differentiation.
- Determine the role of miR-182 in granulopoiesis and its association with AML.
- Identify miR-182 as a potential prognostic marker in AML.
Main Methods:
- Analysis of the regulatory loop between C/EBPα and miR-182.
- Assessment of C/EBPα's effect on miR-182 expression via promoter binding.
- Evaluation of miR-182's impact on C/EBPα protein levels and granulopoiesis in vitro and in vivo.
- Correlation of miR-182 expression with C/EBPα mutations and clinical outcomes in AML patients.
Main Results:
- Oncogenic miR-182 was identified as a key regulator of C/EBPα.
- A negative feedback loop was established: C/EBPα represses miR-182, while miR-182 reduces C/EBPα protein levels.
- Overexpression of miR-182 impaired granulopoiesis.
- Elevated miR-182 expression was observed in AML patients with C-terminal CEBPA mutations.
- miR-182 emerged as a prognostic marker for cytogenetically high-risk AML.
Conclusions:
- A critical balance between C/EBPα and miR-182 is essential for maintaining healthy granulopoiesis.
- The identified regulatory loop plays a significant role in AML pathogenesis.
- miR-182 is a potential biomarker for predicting outcomes in high-risk AML patients.
More Related Videos
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Lineage Commitment
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

